Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

REFERENCES

• Lidegaard Ø, Løkkegaard E, Svendsen AL, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339: b2890.
   PubMed Web of Science ®Google Scholar
• van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, et al. The venous thrombotic risk of oral contraceptives, effects of estrogen dose and progestagen type: results of the MEGA case-control study. BMJ 2009; 339:b2921.
   PubMed Web of Science ®Google Scholar
• Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 2011;340:d2151.
   Web of Science ®Google Scholar
• Parkin L, Sharples K, Hernandez RK, et al. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 2011;340:d2139.
   Web of Science ®Google Scholar
• Lidegaard Ø, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–9. BMJ 2011;343:d6423.
   PubMed Web of Science ®Google Scholar
• Heinemann LAJ, Dinger JC. Range of published estimates of venous thromboembolism incidence in young women. Contraception 2007;75:328–336.
   PubMed Web of Science ®Google Scholar
• Martínez F, Ramírez I, Pérez-Campos E, et al. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Eur J Contracept Reprod Health Care 2012;17:7–29.
   PubMed Web of Science ®Google Scholar
• Dinger JC, Heinemann LAJ, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on Oral Contraceptives based on 142,475 women-years of observation. Contraception 2007;75:344–354.
   PubMed Web of Science ®Google Scholar
• Seeger JD, Loughlin J, Eng PM, et al. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110:587–593.
   PubMed Web of Science ®Google Scholar
• Skjeldestad FE. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives. Contraception 1997;55:11–14.
   PubMed Web of Science ®Google Scholar
• Goodyear-Smith A, Arroll B. Termination of pregnancy following panic-stopping of oral contraceptives. Contraception 2002;66:163–167.
   PubMed Web of Science ®Google Scholar
• Van Vliet HAA, Winkel TA, Noort I, et al. Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate. J Thromb Haemost 2004;2:2060–2062.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Nielsen LH, Skovlund CW, et al. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001–10. BMJ 2012; 344:e2990.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Milsom I, Geirssons RT, et al. Hormonal contraception and venous thromboembolism.Acta Obstet Gynecol Scand 2012;91:769–778.
   PubMed Web of Science ®Google Scholar
• Dinger J, Pineda AA. Risk of VTE in users of an etonogestrel-containing vaginal ring and combined oral contraceptives. Paper presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), San Diego, CA, USA, 7 May 2012.
   Google Scholar
• Spitzer WO. The aftermath of a pill scare: regression to reassurance. Hum Reprod Update 1999;5:736–745.
   PubMed Web of Science ®Google Scholar
• Lewis MA, MacRae KD, Kuhl-Habichl D, et al. The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod 1999;14: 1493–1499.
   PubMed Web of Science ®Google Scholar
• Dinger J. Oral contraceptives and venous thromboembolism: old questions revisited. J Fam Plann Reprod Health Care 2009;35:211–213.
   PubMed Web of Science ®Google Scholar
• Shapiro S, Dinger J. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies. J Fam Plann Reprod Health Care 2010;36:33–38.
   PubMed Web of Science ®Google Scholar
• Heinemann K, Heinemann LA. Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel. J Fam Plann Reprod Health Care 2011;37:132–135.
   PubMed Web of Science ®Google Scholar
• Reid RL, Westhoff C, Mansour D, et al. Oral contraceptives and venous thromboembolism – Consensus opinion from an international workshop held in Berlin, Germany in December2009. J Fam Plann Reprod Health Care 2010;36:117–122.
   Web of Science ®Google Scholar
• Jensen JT, Trussell J. Communicating risk: does scientific debate compromise safety. Contraception 2012;86: 327–329.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medical Eligibility for Contraceptive Use (4th edn). 2010. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html [accessed 6 March 2013].
   Google Scholar
• Dinger J, Shapiro S. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets. J Fam Plann Reprod Health Care 2012;38:2–6.
   PubMed Web of Science ®Google Scholar
• Hannaford PC, Iversen L. Mortality among oral contraceptive users: an evolving story. Eur J Contracept Reprod Health Care 2013;18:1–4.
   PubMed Web of Science ®Google Scholar
• Hannaford PC, Iversen L, MacFarlane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ 2010;340:c927.
   PubMed Web of Science ®Google Scholar
• Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception 2010;82: 221–229.
   PubMed Web of Science ®Google Scholar